MARKET ACCESS 101

MARKET ACCESS 101 
WEDNESDAY, JUNE 14 | 8:45 AM - 5:00 PM 
 Courtyard Toronto Mississauga West
290 Derry Road West, Mississauga, ON L5W 1N6
Book your group rate for CAHR meeting

CAHR's industry-renowned Market Access 101 Conference will be held in-person on June 14th. This course is designed to educate market access professionals and other industry professions on the fundamentals of Canadian pharmaceutical access and reimbursement. Participants gain insights into Canadian reimbursement systems and Payers’ perspectives to develop a broader understanding of the multiple factors required to successfully navigate a product through market access and reimbursement processes. CAHR is pleased to present the return of this industry classic – a primer on everything you need to know about Market Access in Canada, taught by experts in each subject, and the foundation of the Certified Market Access Professional credential. Our accomplished faculty will dive deeply into all aspects of our complex environment – from clinical evidence, HTA agencies and HTA submissions to private and public payers, PMPRB, patient engagement and patient support programs - to empower and reward delegates with information, insights and interpretations that will enhance their careers in Market Access.

PROGRAM AGENDA

8:30am Welcome & Housekeeping
Emcee Jim Shea, CCPE

8:45 am Overview of Market Access and Canadian Landscape

Arvind Mani, Morse Consulting

Market Access in Canada is a broad field encompassing many different areas. Join Arvind Mani as he introduces the field, including what market access entails in the Canadian market and provides an overview of what market access professionals need to know, including an overview of the changing public policy landscape affecting the profession.

9:45am Evidence – Clinical & Real World

Judith Glennie, J.L. Glennie Consulting Inc

This session will focus on the data expectations of payers and HTA bodies, as they evaluate/consider the value of new drug products for drug plan listing. In addition, we will review the evolving role of real-world evidence (RWE) in reimbursement.

10:45 am Networking Break

11:15 am PMPRB

Anna Apostolakis, IQVIA

New PMPRB Regulations were implemented on July 1st. The price tests and guidelines that will be used to operationalize the Regulations are in flux. This presentation will discuss what we know and what we need to watch for in terms of the review of new patented drugs.

12 nn Lunch, AGM & Networking

1:30 pm Introduction to the Private Payer Market

This session will provide a brief overview of private drug coverage in Canada: from where drugs fit overall into employer sponsored benefits, to a discussion on the different types of management strategies insurers use to control drug costs.

2:15 pm PSP Overview with a Focus on: Impacts to Financial Assistance During COVID-19 Structuring a PSP to Support Market Access

Michelle Capon, GSK Canada

This session will cover the basics of a Patient Support Program, including why PSP’s are needed in Canada, key elements of a PSP, a typical PSP journey, drug lifecycle considerations, high level vendor landscape, preparing for an RFP and metrics to measure success.

2:45 pm Networking Break

3:15 pm HTA Basics

Megan Bourque, Eversana

4:30 pm pCPA

Katherine Scott, Morse Consulting

This session will provide an overview of the pan-Canadian Pharmaceutical Alliance (pCPA) including its history, processes, outcomes, and outlook for the future.

5pm Closing Remarks
Emcee Jim Shea, CCPE

5:30pm Networking Reception

Please note: if you're working towards your CMAP Certification you MUST
attend both Market Access 101 and Market Access 201.

REGISTRATION OPENS IN EARLY APRIL!

Remember to check our website, which we suggest you bookmark, as that is where you will find updated information and announcements about all upcoming virtual and in-person programs.

THANK YOU TO OUR PARTNERS

		GOLD
		SILVER
		BRONZE

CAHR reserves the right to cancel or change speakers, content and date without prior notice. We assume no liability for these changes.

Cancellation Policy: For cancellations two (2) weeks or more in advance, delegates will receive a 75% refund. For cancellations made less than two (2) weeks in advance, no refunds are given. Delegate substitutions will be accepted at no cost.